Exagen Inc. logo

Exagen Inc.

NASDAQ:XGN

Overview | Financials
Company Name Exagen Inc.
Symbol XGN
Currency USD
Price 2.79
Market Cap 48,508,056
Dividend Yield 0%
52-week-range 1.3 - 3.71
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. John Aballi
Website https://www.exagen.com

An error occurred while fetching data.

About Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis

Related Stocks

Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc.

PYXS

4.62 USD

Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

LBPH

59.73 USD

Financials

Numbers are in millions USD

Numbers are in millions USD